Key points are not available for this paper at this time.
The solubility and pharmacokinetic properties of 5-fluorouracil were modified by cocrystallization with dihydroxybenzoic acids.
Dai et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: